BEUDAMED
    1,068 results · 40ms · Sources: EU EUDAMED, US FDA

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT™ Venous Endoprosthesis with Unistep Plus™ Delivery System

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent Venous RP & Endoprosthesis with Unistep Plus

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (TIPS,ILAC,VENOUS)ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT ENDOPROSTHESIS (VENOUS)

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent (Venous) Endoprosthesis with Unisteo Plus Delivery System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (VENOUS)ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent Venous Endoprosthesis with Unistep Plus™ Delivery System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent Venous Endoprosthesis with UNISTEP Plus

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT ENDO (VENOUS) STENT SYTEM

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT ENDOPROSTHESIS VENOUS